Novartis AG (ADR) - NVS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Novartis AG (ADR) - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
NVS	New York	2834	http://www.novartis.com/	73.82 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Novartis AG (ADR) 3 Stocks Dragging In The Drugs Industry - May 23rd, 2013 11:03 am Novartis Acknowledges Employees Participated In 'Independent' Trials - May 23rd, 2013 9:09 am 4 Contagion Plays - May 23rd, 2013 8:28 am Another Multiple Sclerosis Winner for Biogen - May 22nd, 2013 2:05 pm Regeneron Shareholders Watching Optina Trial Closely - May 22nd, 2013 1:56 pm FDA Designation for Synageva Candidate - May 22nd, 2013 1:50 pm Is There Growth Left in Massive Drug Stocks? - May 22nd, 2013 11:30 am Ariad's Cancer Drug Iclusig Extends The Gleevec Magic - May 22nd, 2013 11:20 am Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry - May 22nd, 2013 10:56 am Santarus Is a Real Gas! - May 22nd, 2013 7:06 am Is Merck a Buy at These Prices? - May 22nd, 2013 6:43 am Pfizer Stock Checkup for May - May 21st, 2013 3:46 pm Positive Data on Novartis' Afinitor - May 21st, 2013 3:30 pm Flush With Cash, Elan Goes on a Buying Spree - May 21st, 2013 11:44 am Will Influenza A H7N9 Generate Opportunities For Pharma? - May 21st, 2013 7:10 am Johnson & Johnson Stock Checkup for May - May 21st, 2013 12:06 am Actavis buying Warner Chilcott in $8.5B deal - May 20th, 2013 4:36 pm Actavis, Warner Chilcott Stocks Rise On Merger News - May 20th, 2013 4:07 pm Ireland Welcomes Watson Pharmaceuticals, an American Success - May 20th, 2013 12:27 pm Hospital to probe East German medical trials - May 13th, 2013 1:17 pm View All Current Headlines >>